V50F (p.Val50Phe) variant of CALR (Calreticulin)

V50F (p.Val50Phe) in CALR (Calreticulin) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

V50F (p.Val50Phe) variant details